These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 10651939)

  • 21. C5a receptor expression by TGW neuroblastoma cells.
    Farkas I; Baranyi L; Kaneko Y; Liposits Z; Yamamoto T; Okada H
    Neuroreport; 1999 Sep; 10(14):3021-5. PubMed ID: 10549816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complement C5a receptors C5L2 and C5aR in renal fibrosis.
    Martin IV; Bohner A; Boor P; Shagdarsuren E; Raffetseder U; Lammert F; Floege J; Ostendorf T; Weber SN
    Am J Physiol Renal Physiol; 2018 Jan; 314(1):F35-F46. PubMed ID: 28903945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The C5a receptor is expressed by human renal proximal tubular epithelial cells.
    Zahedi R; Braun M; Wetsel RA; Ault BH; Khan A; Welch TR; Frenzke M; Davis AE
    Clin Exp Immunol; 2000 Aug; 121(2):226-33. PubMed ID: 10931135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The C terminus of the human C5a receptor (CD88) is required for normal ligand-dependent receptor internalization.
    Bock D; Martin U; Gärtner S; Rheinheimer C; Raffetseder U; Arseniev L; Barker MD; Monk PN; Bautsch W; Köhl J; Klos A
    Eur J Immunol; 1997 Jun; 27(6):1522-9. PubMed ID: 9209506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Probing the human receptor for C5a anaphylatoxin with site-directed antibodies. Identification of a potential ligand binding site on the NH2-terminal domain.
    Oppermann M; Raedt U; Hebell T; Schmidt B; Zimmermann B; Götze O
    J Immunol; 1993 Oct; 151(7):3785-94. PubMed ID: 8376805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of receptors for complement anaphylatoxins C3a and C5a following permanent focal cerebral ischemia in the mouse.
    Van Beek J; Bernaudin M; Petit E; Gasque P; Nouvelot A; MacKenzie ET; Fontaine M
    Exp Neurol; 2000 Jan; 161(1):373-82. PubMed ID: 10683302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel insights in localization and expression levels of C5aR and C5L2 under native and post-transplant conditions in the kidney.
    van Werkhoven MB; Damman J; Daha MR; Krikke C; van Goor H; van Son WJ; Hillebrands JL; van Dijk MC; Seelen MA
    Mol Immunol; 2013 Mar; 53(3):237-45. PubMed ID: 22960554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Direct binding of a fragment of the Wiskott-Aldrich syndrome protein to the C-terminal end of the anaphylatoxin C5a receptor.
    Tardif M; Brouchon L; Rabiet MJ; Boulay F
    Biochem J; 2003 Jun; 372(Pt 2):453-63. PubMed ID: 12600272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anaphylatoxin C5a receptor mRNA is strongly expressed in Kupffer and stellate cells and weakly in sinusoidal endothelial cells but not in hepatocytes of normal rat liver.
    Schieferdecker HL; Rothermel E; Timmermann A; Götze O; Jungermann K
    FEBS Lett; 1997 Apr; 406(3):305-9. PubMed ID: 9136907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-formylpeptide and complement C5a receptors are expressed in liver cells and mediate hepatic acute phase gene regulation.
    McCoy R; Haviland DL; Molmenti EP; Ziambaras T; Wetsel RA; Perlmutter DH
    J Exp Med; 1995 Jul; 182(1):207-17. PubMed ID: 7540650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complement C5a receptor-mediated signaling may be involved in neurodegeneration in Alzheimer's disease.
    Farkas I; Takahashi M; Fukuda A; Yamamoto N; Akatsu H; Baranyi L; Tateyama H; Yamamoto T; Okada N; Okada H
    J Immunol; 2003 Jun; 170(11):5764-71. PubMed ID: 12759460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C5a receptor targeting in neointima formation after arterial injury in atherosclerosis-prone mice.
    Shagdarsuren E; Bidzhekov K; Mause SF; Simsekyilmaz S; Polakowski T; Hawlisch H; Gessner JE; Zernecke A; Weber C
    Circulation; 2010 Sep; 122(10):1026-36. PubMed ID: 20733098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of functional anaphylatoxin C5a receptors on hepatocytes by in vivo treatment of rats with IL-6.
    Schieferdecker HL; Schlaf G; Koleva M; Götze O; Jungermann K
    J Immunol; 2000 May; 164(10):5453-8. PubMed ID: 10799912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cloning and characterization of the guinea pig C5a anaphylatoxin receptor: interspecies diversity among the C5a receptors.
    Fukuoka Y; Ember JA; Yasui A; Hugli TE
    Int Immunol; 1998 Mar; 10(3):275-83. PubMed ID: 9576615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemoattractant receptors for interleukin-8 and C5a: expression on peripheral blood leukocytes and differential regulation on HL-60 and AML-193 cells by vitamin D3 and all-trans retinoic acid.
    Zahn S; Zwirner J; Spengler HP; Götze O
    Eur J Immunol; 1997 Apr; 27(4):935-40. PubMed ID: 9130647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C5L2 and C5aR interaction in adipocytes and macrophages: insights into adipoimmunology.
    Poursharifi P; Lapointe M; Pétrin D; Devost D; Gauvreau D; Hébert TE; Cianflone K
    Cell Signal; 2013 Apr; 25(4):910-8. PubMed ID: 23268185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C3a and C5a receptor antagonists ameliorate endothelial-myofibroblast transition via the Wnt/β-catenin signaling pathway in diabetic kidney disease.
    Li L; Chen L; Zang J; Tang X; Liu Y; Zhang J; Bai L; Yin Q; Lu Y; Cheng J; Fu P; Liu F
    Metabolism; 2015 May; 64(5):597-610. PubMed ID: 25682062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective effects of IL-6 blockade in sepsis are linked to reduced C5a receptor expression.
    Riedemann NC; Neff TA; Guo RF; Bernacki KD; Laudes IJ; Sarma JV; Lambris JD; Ward PA
    J Immunol; 2003 Jan; 170(1):503-7. PubMed ID: 12496437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sulfated tyrosines contribute to the formation of the C5a docking site of the human C5a anaphylatoxin receptor.
    Farzan M; Schnitzler CE; Vasilieva N; Leung D; Kuhn J; Gerard C; Gerard NP; Choe H
    J Exp Med; 2001 May; 193(9):1059-66. PubMed ID: 11342590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C5a/C5aR pathway accelerates renal ischemia-reperfusion injury by downregulating PGRN expression.
    Zhang K; Li GQ; He QH; Li Y; Tang M; Zheng QY; Xu GL; Zhang KQ
    Int Immunopharmacol; 2017 Dec; 53():17-23. PubMed ID: 29031143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.